Based on the in vitro GBM cells’ sensitivity of patients to chemotherapy drugs and NGF, as well as the levels of blood cells and proteins that are part of the tumor microenvironment, a simple predictive model for assessing the life expectancy of GBM patients has been developed using statistical analysis methods. Here, NGF is linked to glioblastoma.